Wyles, D., Brau, N., Naggie, S., Sulkowski, M., Agarwal, K., Patel, K., … McHutchison, J. (2016). SOF/VEL single-tablet regimen in HCV mono-infected and HIV/HCV co-infected patients: comparison of efficacy and safety data from phase 3 clinical trials. In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (Vol. 19). JOHN WILEY & SONS LTD.

Wyles, David, Norbert Brau, Susanna Naggie, Mark Sulkowski, Kosh Agarwal, Keyur Patel, Nezam Afdhal, et al. “SOF/VEL single-tablet regimen in HCV mono-infected and HIV/HCV co-infected patients: comparison of efficacy and safety data from phase 3 clinical trials.” In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, Vol. 19. JOHN WILEY & SONS LTD, 2016.

Wyles D, Brau N, Naggie S, Sulkowski M, Agarwal K, Patel K, et al. SOF/VEL single-tablet regimen in HCV mono-infected and HIV/HCV co-infected patients: comparison of efficacy and safety data from phase 3 clinical trials. In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. JOHN WILEY & SONS LTD; 2016.

Wyles, David, et al. “SOF/VEL single-tablet regimen in HCV mono-infected and HIV/HCV co-infected patients: comparison of efficacy and safety data from phase 3 clinical trials.” JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 19, JOHN WILEY & SONS LTD, 2016.

Wyles D, Brau N, Naggie S, Sulkowski M, Agarwal K, Patel K, Afdhal N, Liu L, Ding X, Huang K-C, Osinusi A, McNally J, Brainard D, Mertens M, McHutchison J. SOF/VEL single-tablet regimen in HCV mono-infected and HIV/HCV co-infected patients: comparison of efficacy and safety data from phase 3 clinical trials. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. JOHN WILEY & SONS LTD; 2016.